BRL 5.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -151.00 | -167 Thousand | -178 Thousand | -169 Thousand | -169 Thousand | -173 Thousand |
Net Income | -151.00 | -167 Thousand | -177 Thousand | -170 Thousand | -163 Thousand | -176 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -1000.00 | 1000.00 | -6000.00 | 3000.00 |
Other non-cash items | - | - | 1.00 | 2.00 | -6.00 | -3000.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 151.00 | 167 Thousand | 178 Thousand | 169 Thousand | 169 Thousand | 173 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 173 Thousand |
Other Financing Activities | 151.00 | 167 Thousand | 178 Thousand | 169 Thousand | 169 Thousand | 173 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | 3000.00 |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -1000.00 | 1000.00 | - | 3.00 |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | -151.00 | -167 Thousand | -178 Thousand | -169 Thousand | -169 Thousand | -173 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -68 Thousand | -69 Thousand | -21 Thousand | -151.00 | -16 Thousand | -36 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 18 Thousand | -5000.00 | - | - | - | -42 Thousand |
Other non-cash items | -42 Thousand | 69.00 | 4000.00 | - | -4000.00 | -42.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 92 Thousand | 32 Thousand | 17 Thousand | 151.00 | 20 Thousand | 78 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 92 Thousand | 32 Thousand | 17 Thousand | 151.00 | 20 Thousand | 78 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 18 Thousand | 42.00 | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | -92 Thousand | -32 Thousand | -17 Thousand | -151.00 | -20 Thousand | -78 Thousand |
ARFIN
RISE
688509
GELEF
TCSA3
VALIANT